Evaluation of Cell Death and the Reduction of ERK Phosphorylation in Non-Small Cell Lung Cancer Cells after Exposure to Sodium Butyrate |
Park, Ji-Eun
(Department of Anatomy and Cell Biology, College of Medicine, Dong-A University)
Lee, Seung-Gee (Department of Anatomy and Cell Biology, College of Medicine, Dong-A University) Lim, Hyun-Ju (Department of Anatomy and Cell Biology, College of Medicine, Dong-A University) Kim, Ji-Young (Department of Anatomy and Cell Biology, College of Medicine, Dong-A University) Chung, Jin-Yong (Department of Anatomy and Cell Biology, College of Medicine, Dong-A University) Kim, Yoon-Jae (Department of Anatomy and Cell Biology, College of Medicine, Dong-A University) Lee, Chang-Hun (Department of Pathology, Pusan National University School of Medicine) Lee, Min-Ki (Department of Internal Medicine, Pusan National University School of Medicine) Yoo, Ki-Soo (Department of Anatomy and Cell Biology, College of Medicine, Dong-A University) Yoo, Young-Hyun (Department of Anatomy and Cell Biology, College of Medicine, Dong-A University) Kim, Jong-Min (Department of Anatomy and Cell Biology, College of Medicine, Dong-A University) |
1 | Zangemeister-Wittke, U. and R. A. Stahel. 1999. Novel approaches to the treatment of small-celliung cancer. Cell Mol. Life Sci. 55, 1585-1598 DOI ScienceOn |
2 | Zhang, J. H. and M. Xu. 2000. DNA fragmentation in apoptosis. Cell Res. 10, 5-11 DOI ScienceOn |
3 | Zhang, X. D., S. K. Gillespie, J. M. Borrow, and P. Hersey. 2004. The histone deacetylase inhibitor suberic bishydroxamate regulates the expression of multiple apoptotic mediators and induces mitochondria-dependent apoptosis of melanoma cells. Mol. Cancer Ther. 3, 425-435 |
4 | Zimmermann, K. C, C Bonzon, and D. R. Green. 2001. The machinery of programmed cell death. Pharmacol. Ther. 92, 57-70 DOI ScienceOn |
5 | Rosato, R R, S. C. Maggio, J. A Almenara, S. G Payne, P. Atadja, S. SpiegeL P. Dent, and S. Grant. 2006. The histone deacetylase inhibitor LAQ824 induces human leukemia cell death through a process involving XIAP down-regulation, oxidative injury, and the acid sphingomyelinase-dependent generation of ceramide. Mol. Pharmacol. 69, 216-225 |
6 | Sahara, S., M. Aoto, Y. Eguchi, N. Imamoto, Y. Yoneda, and Y. Tsujimoto. 1999. Acinus is a caspase-3-activated protein required for apoptotic chromatin condensation. Nature 401, 168-173 DOI ScienceOn |
7 | Sharma, K R X. Wang, L. Y. Zhang, D. L. Yin, X. Y. Luo, J. C. Solomon, R F. Jiang, K. Markos, W. Davidson, D. W. Scott, and Y. F. Shi. 2000. Death the Fas way: regulation and pathophysiology of CD95 and its ligand. Pharmacal. Ther. 88, 333-347 DOI ScienceOn |
8 | Shivapurkar, N., J. Reddy, P. M. Chaudhary, and A F. Gazdar. 2003. Apoptosis and lung cancer. J. Cell Biochem. 88, 885-898 DOI ScienceOn |
9 | Terao, Y., J. Nishida, S. Horiuchi, F. Rong, Y. Ueoka, T. Matsuda, H. Kato, Y. Furugen, K. Yoshida, K. Kato, and N. Wake. Sodium butyrate induces growth arrest and senescence-like phenotypes in gynecologic cancer cells. Int. J. Cancer 94, 257-267 DOI ScienceOn |
10 | Wada, T. and J. M. Penninger. 2004. Mitogen-activated protein kinases in apoptosis regulation. Oncogene 23, 2838-2849 DOI ScienceOn |
11 | Widlak, P. 2000. The DFF40/ CAD endonuclease and its role in apoptosis. Acta Biochim. Pol. 47, 1037-1044 |
12 | Xia, Z., M. Dickens, J. Raingeaud, R. J. Davis, and M. E. Greenberg. 1995. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270, 1326-1331 DOI ScienceOn |
13 | Yoon, H. S., S. C Moon, N. D. Kim, B. S. Park M. H. Jeong, and Y. H. Yoo. 2000. Genistein induces apoptosis of RPE-J cells by opening mitochondrial PTP. Biochem. Biophys. Res. Commun. 276, 151-156 DOI ScienceOn |
14 | Mai, A, S. Massa, D. Rotili, I. Cerbara, S. Valente, R Pezzi, S. Simeon, and R Ragno. 2005. Histone deacetylation in epigenetics: an attractive target for anticancer therapy. Med. Res. Rev. 25, 261-309 DOI ScienceOn |
15 | Manegold, C. 2001. Chemotherapy for advanced non-small cell lung cancer: standards. Lung Cancer 34 (Suppl), S165-170 DOI ScienceOn |
16 | Marks, P. A, T. M. Richon, T. Miller, and W. K. Kelly. 2004. Histone deacetylase inhibitors. Adv. Cancer Res. 91, 137-168 DOI ScienceOn |
17 | Marks, P. A, T. Miller, and V. M. Richon. 2004. Histone deacetylases. Curro Opin. Pharmacol. 3, 344-351 DOI ScienceOn |
18 | Marks, P. A, V. M. Richon, and R A Rifkind. 2000. Histone deacetylase inhibitors: inducers of differentiation or apoptosis of transformed cells. J. Natl. Cancer Inst. 92,1210-1216 DOI ScienceOn |
19 | Pearson, G, F. Robinson, T. Beers Gibson, B. E. Xu, M. Karandikar, K. Berman, and M. H. Cobb. 2001. Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocrinol. Rev. 22, 153-183 DOI ScienceOn |
20 | Muhlethaler-Mottet, A, R Meier, M. Flahaut, K. B. Bourloud, K. Nardou, J. M. Joseph, and N. Gross. 2008. Complex molecular mechanisms cooperate to mediate histone de acetylase inhibitors anti-tumour activity in neuroblastoma cells. Mol. Cancer 7, 55 DOI ScienceOn |
21 | Rahmani, M., E. Reese, Y. Dai, C. Bauer, S. G Payne, P. Dent, S. SpiegeL and S. Grant. 2005. Coadministration of histone deacetylase inhibitors and perifosine synergistically induces apoptosis in human leukemia cells through Akt and ERKl/2 inactivation and the generation of ceramide and reactive oxygen species. Cancer Res. 65, 2422-2432 DOI ScienceOn |
22 | Reddy, K. B., S. M. Nabha, and N. Atanaskova. 2003. Role of MAP kinase in tumor progression and invasion. Cancer Metastasis Rev. 22, 395-403 DOI ScienceOn |
23 | Davis, R J. 2000. Signal transduction by the JNK group of MAP kinases. Cell 103, 239-252 DOI ScienceOn |
24 | Edwards, A, J. Li, P. Atadja, K. Bhalla, and E. B. Haura. 2007. Effect of the histone deacetylase inhibitor LBH589 against epidermal growth factor receptor-dependent human lung cancer cells. Mol. Cancer Ther. 6, 2515-2524 DOI ScienceOn |
25 | Greenberg, V. L., J. M. Williams, J. P. Cogswell, M. Mendenhall, and S. G Zimmer. 2001. Histone deacetylase inhibitors promote apoptosis and differential cell cycle arrest in anaplastic thyroid cancer cells. Thyroid 11, 315-325 DOI ScienceOn |
26 | Hansen, T. M. and P. Nagley. 2003. AIF: a multifunctional cog in the life and death machine. Sci. STKE. 29, PE31 |
27 | Lansiaux, A, M. Facompre, N. Wattez, M. P. Hildebrand, C. BaL D. Demarquay, O. Lavergne, D. C. Bigg, and C. Bailly. 2001. Apoptosis induced by the homocamptothecin anticancer drug BN80915 in HL-60 cells. Mol. Pharmacol. 60, 450-461 |
28 | Hernandez, A, R Thomas, F. Smith, J. Sandberg, S. Kim, D. H. Chung, and B. M. Evers. 2001. Butyrate sensitizes human colon cancer cells to TRAIL-mediated apoptosis. Surgery 130, 265-272 DOI ScienceOn |
29 | Komatsu, N., N. Kawamata, S. Takeuchi, D. Yin, W. Chien, C. W. Miller, and H. P. Koeffler. 2006. SAHA, a HDAC inhibitor, has profound anti-growth activity against non-small cell lung cancer cells. Oneol. Rep. 15, 187-191 |
30 | Kosmidis, P. A and C. Manegold. 2003. Advanced NSCLC: New cytostatic agents. Lung Cancer 41 (Suppl), S123-132 |
31 | Lee, E. M., S. Shin, H. J. Cha, Y. Yoon, S. Bae, J. H. Jung, S. M. Lee, S. J. Lee, I. C. Park, Y. W. Jin, and S. An. 2009. Suberoylanilide hydroxamic acid (SAHA) changes microRNA expression profiles in A549 human non-small cell lung cancer cells. Int. J. Mol. Med. 24, 45-50 |
32 | Adams, J. M. and S. Cory. 2002. Apoptosomes: engines for caspase activation. Curro Opin. Cell BioI. 14, 715-720 DOI ScienceOn |
33 | Belmokhtar, C. A, J. Hillion, C. Dudognon, S. Fiorentino, M. Flexor, M. Lanotte, and E. Segal-Bendirdjian. 2003. Apoptosome-independent pathway for apoptosis. Biochemical analysis of AP AF-l defects and biological outcomes. J. BioI. Chem. 278, 29571-29580 DOI ScienceOn |
34 | Cross, T. G, D, Scheel-Toellner, N. V. Henriquez, E. Deacon, M. Salmon, and J. M. Lord. 2000. Serine/threonine protein kinases and apoptosis. Exp. Cell Res. 256, 34-41 DOI ScienceOn |
35 | Bidon, N., F. Brichory, D. Thomas, A Cavalier, S. Caulet-Maugendre, P. Bourguet, and L. Dazord. 2001. Sodium butyrate induces growth inhibition and modulates galectin-8 expression in human lung carcinoma cells. Anticancer Res. 21, 1049-1055 |
36 | Chopin, V., R A Toillo, N. Jouy, and X. Le Bourhis. 2002. Sodium butyrate induces P53-independent, Fas-mediated apoptosis in MCF-7 human breast cancer cells. Br. J. Pharmacal. 135, 79-86 DOI ScienceOn |
37 | Cobb, M. H. 1999. MAP kinase pathways. Prog. Biophys. Mol. BioI. 71, 479-500 DOI ScienceOn |
38 | DanieL J. C., and W. R 2003. Smythe. Gene therapy of lung cancer. Semin. Surg. Oneol. 21, 196-204 DOI ScienceOn |